NAVIGATORCO SA/THE financials
NAVIGATORCO SA/THE
549300UNIB7M2AXUXS35 ISIN: PTPTI0AM0006 | Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | €2.09B | €1.95B |
| Other income | €100.8M | €80.3M |
| Employee benefits expense | €203.8M | €172.3M |
| Operating profit (EBIT) | €378.9M | €366.4M |
| Net finance income / (cost) | -€25.8M | -€19.3M |
| Finance costs | €43.2M | €33.4M |
| Profit before tax | €353.0M | €347.0M |
| Income tax expense | €66.0M | €72.1M |
| Profit for the year | €287.0M | €274.9M |
| — attributable to owners | €286.9M | €274.9M |
| — attributable to NCI | €36.0K | €25.3K |
| Total comprehensive income | €295.0M | €255.8M |
| Per share | ||
| Basic EPS | €0.40 | €0.39 |
| Diluted EPS | €0.40 | €0.39 |
| Free cash flow / share | €0.26 | €0.24 |
| Cash flow statement | ||
| Cash generated from operations | €443.0M | €447.8M |
| Net cash from operating activities | €411.5M | €369.1M |
| Net cash from investing activities | -€374.5M | -€256.1M |
| Purchase of PP&E (capex) | €223.7M | €201.1M |
| Purchase of intangibles | €391.3K | €522.6K |
| Net cash from financing activities | €79.8M | -€287.5M |
| Dividends paid | €150.0M | €200.0M |
| Proceeds from borrowings | €352.2M | €15.0M |
| Repayments of borrowings | €124.5M | €107.3M |
| Lease liability payments | €15.7M | €10.7M |
| Net change in cash | €116.7M | -€174.5M |
| Balance sheet | ||
| Total assets | €3.35B | €2.81B |
| Non-current assets | €2.25B | €1.91B |
| Property, plant & equipment | €1.42B | €1.23B |
| Right-of-use assets | €98.7M | €65.0M |
| Intangible assets & goodwill | €422.6M | €381.5M |
| Current assets | €1.11B | €899.1M |
| Inventories | €303.2M | €286.5M |
| Trade & other receivables | €496.7M | €424.7M |
| Cash & equivalents | €286.6M | €169.5M |
| Total equity | €1.36B | €1.32B |
| — attributable to owners | €1.36B | €1.32B |
| Non-controlling interests | €360.3K | €327.0K |
| Non-current liabilities | €1.11B | €861.3M |
| Long-term borrowings | €726.2M | €560.1M |
| Lease liabilities (non-current) | €98.6M | €62.8M |
| Current liabilities | €890.8M | €632.3M |
| Short-term borrowings | €177.7M | €99.3M |
| Lease liabilities (current) | €13.1M | €7.1M |
| Trade & other payables | €658.6M | €503.0M |
| Deferred tax liabilities | €135.9M | €95.9M |
| Derived metrics | ||
| Free cash flow | €187.8M | €168.1M |
| Operating margin | 18.1% | 18.8% |
| Net margin | 13.7% | 14.1% |
| Return on equity | 21.2% | 20.9% |
| Cash conversion ratio | 1.43× | 1.34× |
| Capex coverage | 1.84× | 1.84× |
| Other reported items | ||
| Cash Flows From Losing Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €44.0M | €27.5M |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €150.8M | €55.2M |
| Changes In Inventories of Finished Goods and Work In Progress | €3.5M | €23.7M |
| Changes In Other Provisions | -€32.2K | €1.0M |
| Comprehensive Income Attributable To Noncontrolling Interests | €33.3K | €29.0K |
| Comprehensive Income Attributable To Owners of Parent | €294.9M | €255.8M |
| Current Tax Assets Current | €20.6M | €18.4M |
| Current Tax Liabilities Current | €41.3M | €22.8M |
| Deferred Tax Assets | €59.1M | €23.7M |
| Depreciation Amortisation and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €167.9M | €136.2M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | €416.5K | €890.5K |
| Equity and Liabilities | €3.35B | €2.81B |
| Finance Income | €17.4M | €14.0M |
| Gains Losses On Fair Value Adjustment Biological Assets | -€1.0M | -€6.9M |
| Income Tax Relating To Cash Flow Hedges of Other Comprehensive Income | -€639.2K | -€8.0M |
| Income Tax Relating To Remeasurements of Defined Benefit Plans of Other Comprehensive Income | -€17.7K | €115.5K |
| Income Taxes Paid Refund Classified As Operating Activities | €61.1M | €162.9M |
| Increase Decrease Through Appropriation of Retained Earnings | €14.0M | €34.0M |
| Increase Decrease Through Changes In Ownership Interests In Subsidiaries That Do Not Result In Loss of Control | -€4.5M | — |
| Increase Decrease Through Sharebased Payment Transactions | -€14.0M | -€34.0M |
| Increase Decrease Through Transactions With Owners | -€254.4M | -€200.0M |
| Increase Decrease Through Transfers and Other Changes Equity | €0 | — |
| Inflows of Cash From Investing Activities | €371.9K | €658.5K |
| Intangible Assets Other Than Goodwill | €119.6M | €46.2M |
| Interest Paid Classified As Financing Activities | €18.9M | €4.9M |
| Investment Property | €360.2K | €463.4K |
| Issued Capital | €500.0M | €500.0M |
| Liabilities | €2.00B | €1.49B |
| Noncurrent Biological Assets | €115.3M | €115.6M |
| Noncurrent Payables | €117.2M | €114.7M |
| Noncurrent Receivables | €13.1M | €44.4M |
| Other Comprehensive Income | €8.0M | -€19.1M |
| Other Comprehensive Income Before Tax Cash Flow Hedges | -€1.5M | -€29.1M |
| Other Comprehensive Income Before Tax Exchange Differences On Translation | €8.3M | -€34.7K |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | €563.8K | €3.7M |
| Other Expense By Nature | €52.6M | €58.2M |
| Other Inflows Outflows of Cash Classified As Operating Activities | €29.6M | €84.3M |
| Other Longterm Provisions | €28.4M | €27.8M |
| Other Noncurrent Financial Assets | €1.3M | €0 |
| Outflows of Cash From Investing Activities | €374.9M | €256.8M |
| Payments To and On Behalf of Employees | €162.7M | €145.4M |
| Payments To Suppliers For Goods and Services | €1.55B | €1.54B |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | €371.9K | €658.5K |
| Receipts From Sales of Goods and Rendering of Services | €2.16B | €2.13B |
| Reserve of Cash Flow Hedges | €12.0M | €12.9M |
| Reserve of Exchange Differences On Translation | €13.8M | €5.3M |
| Retained Earnings Excluding Profit Loss For Reporting Period | €548.9M | €418.6M |
| Retained Earnings Profit Loss For Reporting Period | €286.9M | €274.9M |
| Services Expense | €500.9M | €422.4M |
| Share of Other Comprehensive Income of Associates and Joint Ventures Accounted For Using Equity Method That Will Not Be Reclassified To Profit Or Loss Net of Tax | €0 | -€1.5M |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | €0 | €0 |
| Statutory Reserve | €100.0M | €100.0M |
Every line item above is a fact tagged in NAVIGATORCO SA/THE's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.